First National Bank Sioux Falls’s AstraZeneca AZN Stock Holding History

First National Bank Sioux Falls’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-275	Closed	-$18K	–	56
2016 Q3	$18K	Hold	275	–	–	0.05%	181
2016 Q2	$17K	Hold	275	–	–	0.05%	162
2016 Q1	$15K	Hold	275	–	–	0.05%	166
2015 Q4	$19K	Hold	275	–	–	0.06%	152
2015 Q3	$18K	Hold	275	–	–	0.06%	153
2015 Q2	$18K	Hold	275	–	–	0.05%	155
2015 Q1	$19K	Hold	275	–	–	0.06%	155
2014 Q4	$19K	Hold	275	–	–	0.05%	155
2014 Q3	$20K	Hold	275	–	–	0.05%	152
2014 Q2	$20K	Buy	+275	New	+$19.9K	0.05%	153

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

First National Bank Sioux Falls's AZN Position: Q4 2016 in Review

First National Bank Sioux Falls sold out of AstraZeneca (AZN) in Q4 2016, closing a stake of 275 shares — an estimated $18K sold.

First National Bank Sioux Falls first reported a position in AZN in Q2 2014 and held it in 10 quarters. The position peaked at $20K in Q3 2014. 450 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

First National Bank Sioux Falls reported no remaining AstraZeneca position as of Q4 2016 after selling out during the quarter.
First National Bank Sioux Falls sold 275 AstraZeneca shares in Q4 2016, an estimated $18K.
First National Bank Sioux Falls first reported a position in AstraZeneca in Q2 2014 and held it in 10 quarters.
First National Bank Sioux Falls's AstraZeneca position peaked at $20K in Q3 2014.
450 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on First National Bank Sioux Falls's 13F filing for Q4 2016, filed 13 Feb 2017.